Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is DCIS Cancer? Causes, Treatment & Recovery.
What Is DCIS Cancer? Causes, Treatment & Recovery. 4

Getting a dcis cancer diagnosis can be scary, but we’re here to help. DCIS is when abnormal cells stay in the milk ducts of the breast. It’s not in the surrounding tissue, making it a chance for early treatment.

We think knowing about your health is key. Learning about your diagnosis helps you move forward with clarity and confidence. Our team offers support to make sure you get care that fits you.

Finding your way in health care can be tough, but we’re here to help. We’ll guide you through causes and recovery options. Our goal is to help you get the best care possible.

Key Takeaways

  • This condition is a non-invasive form of breast health concern.
  • Early detection leads to exceptional recovery outcomes for most patients.
  • Personalized care plans are essential for effective management.
  • Understanding your diagnosis empowers you to make informed medical decisions.
  • Our specialized team provides comprehensive support throughout your entire journey.

Understanding DCIS Cancer and Its Characteristics

Understanding DCIS Cancer and Its Characteristics
What Is DCIS Cancer? Causes, Treatment & Recovery. 5

We want to help you understand ductal in situ cancer better. When you get a diagnosis, it can feel overwhelming. We aim to make things clear so you can face treatment with confidence.

Defining Ductal Carcinoma In Situ

What is ductal carcinoma in situ? It’s when abnormal cells grow in the milk ducts. But these cells haven’t spread, so it’s not invasive.

Why DCIS Is Classified as Stage 0 Breast Cancer

Many wonder, is DCIS considered breast cancer? Yes, it’s classified as stage 0 because the cells are contained. This helps doctors choose the best treatment for you.

It’s a warning sign but not deadly yet. Knowing cis breast cancer is stage 0 can ease your mind. It means you can get treatment before it gets worse.

The Distinction Between Non-Invasive and Invasive Breast Cancer

It’s important to know the difference for your treatment. The question is dcis cancer or not is common. But focus on the cells being contained.

The table below shows the main differences between DCIS and invasive breast cancer.

FeatureDCIS (Stage 0)Invasive Breast Cancer
Cell LocationConfined to milk ductsSpread to surrounding tissue
InvasivenessNon-invasiveInvasive
Risk LevelPrecursor riskNeeds immediate treatment
Treatment GoalPrevent future growthRemove and treat

Understanding what is ductal growth helps manage your health. Whether you’re researching n situ breast cancer or need guidance, we’re here. Our team is committed to helping you through this.

Identifying Symptoms and Diagnostic Methods

Identifying Symptoms and Diagnostic Methods
What Is DCIS Cancer? Causes, Treatment & Recovery. 6

Early-stage breast conditions often don’t show clear warning signs. This is why regular screening is key. We believe knowing your health facts helps you take charge of your well-being.

Why Most Cases Are Asymptomatic

Cis breast conditions often don’t show any clear signs. This is why they are often called silent in their early stages.

With no clear cis symptoms, people might feel fine. So, regular doctor visits are a big part of staying healthy.

The Role of Routine Mammography Screening

Routine mammograms are the main way to find cis breast cancer. Radiologists look for microcalcification clusters during these tests.

These small calcium spots show up as white dots on scans. If found, we do a biopsy to confirm and plan your care.

Recognizing Possible Physical Signs

Some people might notice changes that need a doctor’s check. Look out for new lumps, itchy skin, or nipple discharge.

Don’t ignore cis symptoms breast cancer signs, even if they seem small. Tell your doctor about any unusual changes to get a quick and accurate check-up of your cis breast health.

Causes, Risk Factors, and Treatment Approaches

The exact cause of DCIS is a topic of ongoing research. We know that certain cellular changes lead to its development. Understanding these changes helps us provide the best care for our patients.

The Biological Basis of Cell Mutations

Ductal carcinoma-in-situ happens when cells in the milk ducts mutate. These mutations cause the cells to grow out of control but stay inside the ducts.

Because these cells don’t spread, DCIS is called noninvasive ductal carcinoma. We focus on finding these changes early to stop the disease from getting worse.

Primary Risk Factors for Developing DCIS

Many wonder, “hat is the cause of dcis?” There’s no single cause, but several factors increase your risk. Being female, having a family history of breast cancer, and being over 30 are all risk factors.

Your personal health history also affects your risk. We carefully consider these factors to create a screening plan that meets your needs.

Standard Treatment Options and Prognosis

The outlook for ductal carcinoma is very good, with over 98 percent of people surviving five years after diagnosis. Our team works with you to create a treatment plan that focuses on your long-term health.

Depending on the cis types and your medical history, we might suggest surgery, radiation, or hormonal therapy. We always consider your preferences when choosing the best treatment for your uctal carcinoma in.

Treatment MethodPrimary GoalCommon Application
Breast-Conserving SurgeryRemove affected tissueStandard for localized cases
Radiation TherapyDestroy remaining cellsUsed after surgery
Hormonal TherapyBlock growth signalsFor hormone-receptor-positive cases

We are dedicated to supporting you every step of the way. By combining the latest medical science with caring support, we ensure you get the best treatment for uctal carcinoma.

Conclusion

Getting a diagnosis of ductal carcinoma in situ can feel scary at first. But remember, this stage 0 condition is very treatable. You have a great chance of a long-term recovery.

Regular screenings are your best defense against health problems. They help doctors keep an eye on you and catch any issues early.

Having a specialized medical team by your side is key. They will give you care that fits your needs. We’re here to support you every step of the way.

Our experts at Mayo Clinic and MD Anderson Cancer Center are here to help. Contact us to talk about your situation. We’ll help you figure out the best steps for your health.

FAQ

What is ductal carcinoma in situ and how is it defined?

Ductal carcinoma in situ (DCIS) is an early form of breast cancer where abnormal cells are found inside the milk ducts. It is considered non-invasive because it has not spread into surrounding breast tissue.

Is dcis considered breast cancer or not?

Yes, DCIS is considered a type of breast cancer, but it is non-invasive. It is often described as stage 0 breast cancer.

What are the primary cis symptoms breast cancer patients should look for?

DCIS usually does not cause noticeable symptoms. It is most often detected through routine mammograms rather than physical signs.

What is the cause of dcis and what are the risk factors?

DCIS develops due to genetic changes in breast duct cells. Risk factors include age, family history, hormonal exposure, and prior breast conditions.

How do we diagnose ductal in situ cancer during a screening?

DCIS is commonly detected on mammograms as tiny calcium deposits called microcalcifications. A biopsy is then used to confirm the diagnosis.

What are the standard treatment options for dcis cancer?

Treatment options include surgery such as lumpectomy or mastectomy, often combined with radiation therapy. Hormone therapy may also be used in some cases.

Why is it important to distinguish between non-invasive and invasive dcis breast conditions?

Distinguishing is important because non-invasive DCIS has not spread and has a much better prognosis. Invasive cancer requires more aggressive treatment due to spread risk.

Reference:

 The Lancet. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30503-3/fulltext

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75